| Prev Close | 363.82 |
| Day Low/High | 360.01 / 377.80 |
| 52 Wk Low/High | 196.78 / 380.76 |
| Avg Volume | 1.36M |
Illumina Inc. (ILMN)
374.60
11.00
3.00
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 147.00M |
| Market Cap | 52.10B |
| EPS | 6.80 |
| P/E Ratio | 57.38 |
| Div & Yield | N.A. (N.A) |
Does Illumina Have the Genes for Lasting Growth?
This week's introduction of the NovaSeq Series of genomic sequencers caused the stock to jump.
Illumina: The Bears Have Taken Control
Considering the major top formation, don't get in their way.
Bullish and Bearish Reversals for the Week
Technology stocks dominate the bearish ledger this week.
Trader's Daily Notebook: You Might Consider Selling Facebook
Do that if you like top ticking crowd favorites, but set a protective stop.
Avoid Twitter Like the Plague; It's Uninvestable
If Twitter puts up a dreadful quarter, shares will sell off again.
My Takeaways and Observations
The media is not the message. With a little help from Johnny Mercer, did you know he founded Capitol Records? Â This is serious folks -- I see less of a reason to have an outsized long portfolio than at any time since Winter 2007. The market outlook...
Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide
On days like this, the money just keeps sloshing around.
Midday Report: Yum! Brands Climbs on Franchise Plan; U.S. Stocks Slide
U.S. stocks slipped after a disappointing quarterly performance from Alcoa soured optimism over earnings season.
Illumina Shares Hammered by Sales Forecast Cut
Cantor Fitzgerald says Illumina's outlook revision is not likely to affect industry peers.
Morning Movers: ILMN, STJ, AA, MRO, CHK
Shares of Illumina were tanking before the opening bell after unveiling a disappointing sales forecast.
Back in the Saddle With Some Brief Takeaways
Back from my meetings to find the S&P 500 Index basically traded in a 2-3 point range over the last four hours, which is a statistically improbable event!  Highs were made early in the day when I issued my Trade of the Week (short SPDR S&P 500 ETF ...
Illumina Faces a Bumpy Ride for a Few Quarters
I have been a big bull on its technology, but I am sidelined right now.
Bullish and Bearish Reversals for the Week
Lots of energy names facing the potential for lower prices.
Illumina Lights Up in Radiant Rally
Following the positive action over the last four days, an upside resolution now appears likely.
This Laggard Is Set to Shine
Illumina is moving toward higher ground.
Illumina's Future Looks Very Bright
Charts show ILMN is close to offering a great profit opportunity.
Novice Trade: Illumina
ILMN's three-month at-the-money implied volatility is at about the median level.
Illumina Could Light Up; a Reversal Is in the Works
With very low oversold readings and a possible reversal pattern, we would at least cover shorts, and would consider probing the long side.
Today's Takeaways and Observations (Monarch Notes Edition --- Because I Am Beat).
My thoughts on the day: The five-day market win streak stalled a bit today. Though the close was weak, I still give the win to the bulls because of the modest drop in the averages after an 80-handle rise in the S&P index. That said, there was less t...
Are Drug Stocks What's Ailing the Market?
This move in health care takes your breath away.
Jared Woodard Intermediate Trade: IBB
Take advantage of elevated option premiums to gain long exposure to biotech.
Illumina Plummets on Weak Sales Forecast; Biotech Stocks Fall
DNA sequencing company Illumina (ILMN) plummeted in midday trading Tuesday after reporting disappointing preliminary sales for its third quarter.
Illumina Dims, but It's Still Set Up to Shine
With such a commanding lead in the sequencing business the stock can't stay down for long.
